Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Apr 22;17(4):e82762.
doi: 10.7759/cureus.82762. eCollection 2025 Apr.

Exploring the Evolution of Breast Cancer Imaging: A Review of Conventional and Emerging Modalities

Affiliations
Review

Exploring the Evolution of Breast Cancer Imaging: A Review of Conventional and Emerging Modalities

Maria Gabriela Cerdas et al. Cureus. .

Abstract

Breast cancer (BC) is one of the leading causes of malignancy among women, and its prevalence is exponentially rising globally. Early and accurate imaging is critical for early detection, diagnosis, and treatment planning. This comprehensive review explores the current status of BC imaging, from the conventional methods such as mammography, ultrasound (US) and magnetic resonance imaging (MRI) to more advanced techniques including contrast-enhanced imaging, tomosynthesis, and molecular breast imaging (MBI). Conventional imaging remains the foundation for screening, as mammography is the most widely preferred modality. US and MRI are usually employed in dense breasts in highly suspicious cases that are not detected on a mammogram. However, the limitations posed by these traditional techniques can be curtailed using advanced modalities to enhance diagnostic accuracy. These emerging techniques provide faster and earlier detection of malignancy, particularly in high-risk patients, and substantially reduce the burden of missed cases. Emerging technologies, including photoacoustic imaging (PAI) and contrast-enhanced ultrasound (CEUS), show promising potential in visualizing microvascular structures and enhancing diagnostic accuracy. Additionally, artificial intelligence (AI) is revolutionizing BC imaging across all modalities by optimizing interpretation, enhancing sensitivity, and enabling personalized risk assessment. Although technological innovation continues to improve imaging quality and diagnostic precision, challenges such as cost, accessibility, overdiagnosis, and disparities in care remain a concern. Moving forward, a collaborative multimodal strategy that incorporates personalized imaging protocols and equitable access will be crucial for improving BC screening and management. The future of breast imaging lies not in replacing existing modalities but in developing a system where each technology complements the other, leading to earlier detection, more effective treatment, and enhanced outcomes.

Keywords: breast cancer; breast ultrasound; contrast-enhanced mammogram; contrast-enhanced ultrasound (ceus); magnetic resonance imaging breast; mammography; molecular breast imaging; photoacoustic imaging; positron emission tomography computed tomography.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

Figures

Figure 1
Figure 1. Overview of role of radiological imaging in screening and detection of breast cancer
BI-RADS: Breast imaging-reporting and data system The figure has been made by Humza Siddiqui using biorender.com

Similar articles

References

    1. Breast cancer statistics 2024. Giaquinto AN, Sung H, Newman LA, et al. CA Cancer J Clin. 2024;74:477–495. - PubMed
    1. Trends in incidence, prevalence, and survival of breast cancer in the United Kingdom from 2000 to 2021. Barclay NL, Burn E, Delmestri A, et al. Sci Rep. 2024;14:19069. - PMC - PubMed
    1. Trends in female breast cancer among adolescent and young adults in Southeast Asia. Chen J, Ho FD, Feliciano EJ, Wu JF, Magsanoc-Alikpala K, Dee EC. Lancet Reg Health Southeast Asia. 2025;34:100545. - PMC - PubMed
    1. Breast cancer: pathogenesis and treatments. Xiong X, Zheng LW, Ding Y, et al. Signal Transduct Target Ther. 2025;10:49. - PMC - PubMed
    1. Early diagnosis of breast cancer. Wang L. Sensors (Basel) 2017;17:1572. - PMC - PubMed

LinkOut - more resources